Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FBGQP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,872
Award facts
- Contract value 100% obligated
- $46,871.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitive delivery order valued at $46,871.80 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. The order was placed on September 24, 2025, with an ultimate completion date of October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. This IDC serves as the primary contracting mechanism enabling AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide.
The delivery order employs firm fixed pricing with no set-aside designation, reflecting AmerisourceBergen's competitive capability to meet federal procurement requirements through open competition. The award demonstrates the contractor's role as a critical vendor within the Defense Health Agency supply chain, providing specialized pharmaceutical products including biologics and specialty medications to support military beneficiaries. As the prime contractor under the DLA Troop Support Medical umbrella, AmerisourceBergen continues to serve as one of the designated pharmaceutical prime vendors for the defense healthcare system across multiple therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DB25FBGQP?
SPE2DB25FBGQP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FBGQP worth?
The government has obligated $46,872 on SPE2DB25FBGQP.
Is contract SPE2DB25FBGQP an order under another contract?
Yes. SPE2DB25FBGQP is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGQP competed?
The extent of competition for SPE2DB25FBGQP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award